Houston, TX, United States of America

Clyde W Wellen

This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Agritec, Inc., Research Development Foundation, Other. Active years: 1998-2008.


% Patents Active = 66.7



Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 110(Granted Patents)


Company Filing History:


Years Active: 1998-2008

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Clyde W Wellen: Innovator in Anti-Cancer Drug Delivery

Introduction

Clyde W Wellen is a notable inventor based in Houston, TX, who has made significant contributions to the field of medical technology. With a total of six patents to his name, Wellen has focused on innovative methods for delivering anti-cancer drugs effectively.

Latest Patents

Wellen's latest patents include groundbreaking inventions such as "Small particle liposome aerosols for delivery of anti-cancer drugs." This invention involves lipid- or water-soluble anti-cancer drugs incorporated into liposomes, which are administered via jet nebulizers to the respiratory tract. This method allows for faster and more efficient absorption of the drugs compared to traditional administration methods. Another significant patent is the "Antibody delivery system for biological response modifiers," which provides a novel conjugate comprising an antibody directed toward specific cell surface-associated antigens and a biological response modifier moiety. This invention aims to treat proliferative cell diseases effectively.

Career Highlights

Throughout his career, Clyde W Wellen has worked with various organizations, including Agritec, Inc. and the Research Development Foundation. His work has focused on developing innovative solutions that enhance the efficacy of cancer treatments.

Collaborations

Wellen has collaborated with notable individuals in his field, including Douglas K Stephens and Greg R Wellen. These collaborations have contributed to the advancement of his research and the

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…